Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
17-18 February, 2026
Village de la ChimieVillage de la Chimie
Not Confirmed
Not Confirmed
18-19 February, 2026
Linear SPPS vs Conjuga...Linear SPPS vs Conjugation of SPPS
Not Confirmed
Not Confirmed
18 February, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-18 February, 2026
Village de la ChimieVillage de la Chimie
Industry Trade Show
Not Confirmed
18-19 February, 2026
Linear SPPS vs Conjuga...Linear SPPS vs Conjugation of SPPS
Industry Trade Show
Not Confirmed
18 February, 2026
Digital content

02 Feb 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/02/02/3230149/0/en/Palvella-Therapeutics-Announces-Scientific-Publication-in-Clinical-and-Experimental-Dermatology-Highlighting-a-Systematic-Review-of-Real-World-Statin-Evidence-and-Persistent-Treatm.html

09 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/09/3216029/0/en/Palvella-Therapeutics-Provides-Corporate-Update-and-2026-Outlook-Advancing-a-Late-Clinical-Stage-Pipeline-and-Platform-to-Address-Multiple-Serious-Rare-Skin-Diseases-and-Vascular-M.html

07 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/07/3214427/0/en/Palvella-Therapeutics-Strengthens-Leadership-Team-with-Appointment-of-Veteran-Medical-Affairs-Leader-Vimal-Patel-PharmD-as-Senior-Vice-President-of-Medical-Affairs.html

16 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/16/3206115/0/en/Palvella-Therapeutics-Granted-FDA-Fast-Track-Designation-for-QTORIN-3-9-Rapamycin-Anhydrous-Gel-QTORIN-rapamycin-for-the-Treatment-of-Angiokeratomas.html

15 Dec 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/12/15/3205242/0/en/Palvella-Therapeutics-Announces-Positive-Topline-Results-from-Phase-2-TOIVA-Clinical-Trial-of-QTORIN-3-9-Rapamycin-Anhydrous-Gel-QTORIN-rapamycin-for-the-Treatment-of-Cutaneous-Ven.html

11 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/11/3185323/0/en/Palvella-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
ABOUT THIS PAGE